Mesa Laboratories (MLAB) Misses Q3 EPS by 82c, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Mesa Labs Announces Third Quarter Results
February 3, 2026 8:00 AM ESTLAKEWOOD, Colo., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (Mesa or the Company), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its third fiscal quarter (3Q26) ended December 31, 2025 (amounts in thousands).
3Q26 Financial Summary (comparisons are versus the same year ago period
Revenues increased 3.6%Non-GAAP organic and core organic revenues1 growth was 3.6% and 1.2%, respectivelyNon-GAAP organic revenues growth excluding CG China revenues (entirely diagnostics) was 5.7%Operating income increased 38.0%... More